Department of Chemistry, Christ University, Hosur Road, Bengaluru, 560029, India.
Top Curr Chem (Cham). 2024 Aug 14;382(3):28. doi: 10.1007/s41061-024-00473-w.
The enzyme-mimicking nature of versatile nanomaterials proposes a new class of materials categorized as nano-enzymes, ornanozymes. They are artificial enzymes fabricated by functionalizing nanomaterials to generate active sites that can mimic enzyme-like functions. Materials extend from metals and oxides to inorganic nanoparticles possessing intrinsic enzyme-like properties. High cost, low stability, difficulty in separation, reusability, and storage issues of natural enzymes can be well addressed by nanozymes. Since 2007, more than 100 nanozymes have been reported that mimic enzymes like peroxidase, oxidase, catalase, protease, nuclease, hydrolase, superoxide dismutase, etc. In addition, several nanozymes can also exhibit multi-enzyme properties. Vast applications have been reported by exploiting the chemical, optical, and physiochemical properties offered by nanozymes. This review focuses on the reported nanozymes fabricated from a variety of materials along with their enzyme-mimicking activity involving tuning of materials such as metal nanoparticles (NPs), metal-oxide NPs, metal-organic framework (MOF), covalent organic framework (COF), and carbon-based NPs. Furthermore, diverse applications of nanozymes in biomedical research are discussed in detail.
多功能纳米材料的酶模拟特性提出了一类新型材料,被归类为纳米酶或纳米模拟酶。它们是通过功能化纳米材料制造的人工酶,产生类似于酶的功能的活性位点。这些材料的范围从金属和氧化物扩展到具有内在酶样特性的无机纳米颗粒。纳米酶可以很好地解决天然酶的高成本、低稳定性、分离困难、可重复使用性和储存问题。自 2007 年以来,已经报道了 100 多种模拟过氧化物酶、氧化酶、过氧化氢酶、蛋白酶、核酸酶、水解酶、超氧化物歧化酶等酶的纳米酶。此外,一些纳米酶还可以表现出多种酶的特性。通过利用纳米酶提供的化学、光学和物理化学特性,已经报道了广泛的应用。本综述重点介绍了各种材料制备的纳米酶及其酶模拟活性,涉及对金属纳米颗粒 (NPs)、金属氧化物 NPs、金属有机框架 (MOF)、共价有机框架 (COF) 和碳基 NPs 等材料的调谐。此外,还详细讨论了纳米酶在生物医学研究中的多种应用。
Top Curr Chem (Cham). 2024-8-14
Acc Chem Res. 2020-7-21
Chem Commun (Camb). 2020-9-29
Acc Chem Res. 2019-7-5
Int J Biol Macromol. 2022-1-1
J Mater Chem B. 2019-1-18
Nanotechnology. 2024-6-21
Acc Chem Res. 2014-1-17
J Mol Model. 2023-1-19
RSC Adv. 2019-12-23
Bioact Mater. 2022-2-1